Asimov Company
Asimov employs artificial intelligence to develop tools for the design and manufacture of next-generation therapeutics.
Investors
Founded Date:
2017-01-01
Total Funding:
205000000.0
Investor Type:
hello@asimov.com
Employee Number:
11-50
Funding Status:
Early Stage Venture
Technology:
['BioTech & HealthTech']
Last Funding Type:
Series B
Investors Number:
9.0
Last Funding Date:
2023-01-05
Industry:
Medical BioTech
Headquarters:
Boston, Massachusetts, United States
Estimated Revenue:
$1M to $10M